Boston Scientific (BSX) Hisse Fiyat
Boston Scientific Fiyat
Gelir, son 19 yılda yıllık bileşik %5,1 artarak 20,07 Md USD seviyesine ulaştı. Hisse başına kâr, son 14 yılda yıllık %14,1 büyüdü. Boston Scientific şirketinde net marj %14,4 seviyesinde bulunuyor; birkaç yıl önceki %8,7 seviyesine göre yükseldi. Analistler 50,50 USD medyan fiyat hedefi belirliyor; bu, güncel fiyatın %20,3 üzerinde bir seviyeye işaret ediyor. 37 analistten 24 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Boston Scientific hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Boston Scientific iş modeli ve hisse analizi
Boston Scientific hakkında sık sorulan sorular
The main competitors of Boston Scientific Corp in the market include Medtronic, Johnson & Johnson, Abbott Laboratories, and Edwards Lifesciences.
Boston Scientific Corp is a global medical technology company. Its business model revolves around developing innovative medical solutions that enhance patient care and healthcare outcomes. Boston Scientific Corp manufactures and markets a broad range of medical devices used in various specialties, such as cardiology, urology, endoscopy, and neuromodulation. The company's commitment to research and development enables it to introduce advanced technologies and therapies that address unmet clinical needs. Boston Scientific Corp also focuses on collaborations and partnerships to expand its product portfolio, improve access to healthcare, and provide high-quality medical devices to patients worldwide.
Boston Scientific Corp is primarily active in the medical equipment and supplies industry.
Boston Scientific Corp is a renowned medical technology company based in Marlborough, Massachusetts. Established in 1979, it has become a global leader in the development, manufacturing, and marketing of innovative medical devices. With a focus on advancing patient care, Boston Scientific Corp offers a wide range of products for various medical specialties, including interventional cardiology, urology, endoscopy, and neuromodulation. The company's history showcases its commitment to medical breakthroughs and improving the lives of patients worldwide. Boston Scientific Corp's dedication to cutting-edge technology and strategic acquisitions has allowed it to maintain a prominent position in the healthcare industry.
Boston Scientific Corp has achieved significant milestones throughout its history. Some notable achievements include the development of the Taxus Express, a groundbreaking drug-eluting stent that revolutionized the treatment of coronary artery disease. Additionally, the acquisition of Guidant Corporation strengthened Boston Scientific's position in the field of cardiac rhythm management. The company's innovative products, such as the Watchman Left Atrial Appendage Closure device, have provided improved treatment options for patients with atrial fibrillation. Boston Scientific Corp continues to innovate and make advancements in medical technologies, helping to improve patient outcomes worldwide.
Boston Scientific Corp is primarily present in several countries and regions worldwide. The company has a strong global presence, with significant operations in the United States, Europe, Asia-Pacific, Latin America, and the Middle East. Its diverse market reach spans across more than 130 countries, enabling Boston Scientific Corp to provide innovative medical solutions and technologies to a vast range of patients and healthcare professionals worldwide.
Boston Scientific Corp represents values of innovation, collaboration, and patient-centricity. With a strong corporate philosophy focused on improving patients' lives, the company is committed to developing and delivering innovative medical solutions. Boston Scientific Corp's dedication to collaboration extends to its partnerships with healthcare professionals and institutions, helping to address unmet needs and improve patient outcomes. By prioritizing patient-centric care, the company ensures that its products and services are designed to provide effective and meaningful treatments. Boston Scientific Corp's continued commitment to innovation and collaboration underscores its mission to transform lives through medical advancements in a rapidly evolving healthcare landscape.
Analistler şu anda Boston Scientific hissesi için ortalama 53,77 USD hedef fiyat belirliyor (medyan: 50,50 USD); bu, son fiyata göre +25,1 % anlamına gelir. Konsensüs 37 analist notuna dayanır.
37 analist şu anda Boston Scientific hissesini değerlendiriyor: 24 al, 12 tut, 1 sat öneriyor. 2026 için analistler Boston Scientific şirketinin 20,97 Md USD gelir ve 3,14 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Boston Scientific hissesi 38,23 EUR (41,98 USD) seviyesindedir.
Boston Scientific hissesi (BSX) 10 borsada işlem görür, bunlar arasında: NYSE (BSX), London (0HOY.L), SIX (Zürich) (BSX.SW), XETRA (BSX.DE), Frankfurt (BSX.F), München (BSX.MU), Düsseldorf (BSX.DU), Wien (BSXC.VI).
The Boston Scientific Corporation is a medical technology company that specializes in the manufacturing and development of medical devices. The company was founded in Massachusetts in 1979 and operates globally today. Its business model includes various divisions that focus on different medical specialties. The Cardiac Rhythm Management division of Boston Scientific is involved in the manufacturing of devices for the treatment of heart rhythm disorders. This includes products such as implantable defibrillators, pacemakers, and accessories. The products in this division are of high quality and have an excellent track record in treating patients with severe heart problems. The Interventional Cardiology division of Boston Scientific specializes in the manufacturing of products used in the treatment of heart diseases. This includes balloon catheters, stents, and catheter ablation systems. These products are typically minimally invasive and allow for a quick restoration of normal heart rhythm in patients. The Interventional Radiology division of Boston Scientific is focused on the manufacturing of products for the diagnosis and treatment of vascular diseases. The company produces catheters, stents, and embolization accessories, among other things. Additionally, Boston Scientific is also specialized in the development of products for the treatment of chronic pain. The products in this division include implantable pain therapy systems, neurostimulators, and accessories. These devices can alleviate patients' pain and improve their quality of life. The company is also specialized in the field of urology, including products for the treatment of conditions such as urinary incontinence and benign prostatic hyperplasia. Boston Scientific produces mesh implants and devices aimed at improving bladder control. Furthermore, the company has a division dedicated to gastrointestinal diseases, including products for the treatment of conditions like colorectal cancer and gastrointestinal bleeding. The portfolio includes endoscopes, balloon catheters, and other devices for the treatment of digestive tract disorders. Boston Scientific is committed to providing its customers with the best products. Product development is strongly focused on meeting the needs of patients and doctors. By continually developing new products, the company can expand its market position and maintain its leading position in the medical technology industry.
beklenen'nin Boston Scientific hasılatı 20,97 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Boston Scientific karı 4,69 Md USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Boston Scientific'nin Fiyat/Kazanç (F/K) oranı şu anda 13,39'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Boston Scientific hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Boston Scientific'nin Fiyat/Satış (F/S) oranı şu anda 2,99'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Boston Scientific hisse senedinin değerleme metriği olarak hizmet eder.
Boston Scientific'nin Eulerpool Kalite Puanı 5/10'dur.
Boston Scientific'nin ISIN'i US1011371077'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Boston Scientific'nin WKN'i 884113'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Boston Scientific'nin ticker'ı BSX'dir. Ticker sembolü, Boston Scientific hisseleri borsada işlem görmek için kullanılır.
Boston Scientific Hissesi
Boston Scientific Emsaller Grubu
Boston Scientific Ticker
Boston Scientific FIGI
Boston Scientific'nin tüm temel göstergeleri ve derinlemesine analizi
Boston Scientific hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Boston Scientific şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz:





